Back
Trinity Biotech PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
13
TRIB
Trinity Biotech PLC
Last Price:
1.37
Seasonality Move:
6.79%
Sell
4
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.59
Seasonality Move:
50.57%
Sell
13
Trinity Biotech PLC (TRIB)
is a Sell
Is Trinity Biotech PLC a Buy, Sell or Hold?
- The current Trinity Biotech PLC [TRIB] share price is $1.37. The Score for TRIB is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- TRIB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
4
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.59. The Score for ADAP is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
TRIB Stock Price Chart
What is Trinity Biotech PLC's stock price today?
-
The Trinity Biotech PLC share price today is $1.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRIB is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
TRIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 36.72 | Sell |
Chaikin Money Flow: | -34438 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.54 - 1.88) | Sell |
Bollinger Bands (100): | (1.44 - 2.64) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 26.27 | Sell |
Chaikin Money Flow: | -2051103 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.7 - 0.86) | Sell |
Bollinger Bands (100): | (0.83 - 1.21) | Sell |
TRIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.58 | Sell |
20-day SMA: | 1.7 | Sell |
50-day SMA: | 1.57 | Sell |
200-day SMA: | 2.07 | Sell |
8-day EMA: | 1.56 | Sell |
20-day EMA: | 1.64 | Sell |
50-day EMA: | 1.72 | Sell |
200-day EMA: | 2.15 | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.75 | Sell |
20-day SMA: | 0.76 | Sell |
50-day SMA: | 0.88 | Sell |
200-day SMA: | 1.13 | Sell |
8-day EMA: | 0.71 | Sell |
20-day EMA: | 0.77 | Sell |
50-day EMA: | 0.87 | Sell |
200-day EMA: | 1.01 | Sell |
Trinity Biotech PLC Earnings Growth & TRIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and an increase next year of $0.84 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.33 per share.
Trinity Biotech PLC Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |